Yestar Group’s US$200 Million Restructuring

Dechert has advised Yestar Healthcare Holdings Company Limited on the transaction.Yestar Healthcare Holdings Company Limited, a leading distributor and service provider of in vitro diagnostic products…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here